Erratum: P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy (International Journal of Cardiology (2003) 94 (163-166) DOI: 10.1016/j.ijcard.2003.01.001);P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy

International Journal of Cardiology

Volumn 94, Issue 2-3, 2004, Pages 163-166

  Ozdemir, Ozcan ^a  

^a 06200 Ankara Turkey   (Turkey)

Author keywords

Atrial fibrillation; Hypertrophic cardiomyopathy; P wave durations

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MEASUREMENT; P WAVE; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 1842828916     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.10.001     Document Type: Erratum

References (20)

1. Wigle E.D. The diagnosis of hypertrophic cardiomyopathy. Heart. 86:2001;709-714.
2. Glancy D.L., O'Brien K.P., Gold H.K., Epstein S.E. Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenoses. Br. Heart J. 32:1970;652-659.
3. Robinson K., Frenneaux M.P., Stockins B., Karatasaki S.G., Poloniecki J.D., McKenna W.J. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J. Am. Coll. Cardiol. 15:1990;1286-1287.
4. Maron B.J. Hypertrophic cardiomyopathy. Lancet. 12:(350):1997;127-133.
5. Shakespeare C.F., Keeling P.J., Slade A.K., McKenna W.J. Arrhythmia and hypertrophic cardiomyopathy. Arch. Mal. Coeur Vaiss. 85:(Spec no. 4):1992;31-36.
6. Olivotto I., Cecchi F., Casey S.A., Dolara A., Traverse J.H., Maron B.J. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 104:(21):2001;2517-2524.
7. Dilaveris P.E., Gialafos E., Andrikopoulos G.K., Richter D.J., Papanikolaou V., Poralis K., et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pace Pacing Clin. Electrophysiol. 23:(3):2000;35-38.
8. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on clinical application of echocardiography) developed in collaboration with the American Society of Echocardiography. Circulation 1997;95:1686-774.
9. Klues H.G., Schiffers A., Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and clinical significance as assessed by two-dimensional echocardiography in 600 patients. J. Am. Coll. Cardiol. 26:1995;1699-1708.
10. Greenspan A.M. Hypertrophic cardiomyopathy and atrial fibrillation: a change of perspective. J. Am. Coll. Cardiol. 15:1990;1286-1287.
11. Doi Y., Kitaoka H. Hypertrophic cardiomyopathy in elderly: significance of atrial fibrillation. J. Cardiol. 37:(Suppl. 1):2001;133-138.
12. Samukawa M., Hasegawa K., Harada Y., Nakao M., Tadaoka S., Yoneda M., et al. Clinical features and significance of hypertrophic cardiomyopathy with atrial fibrillation. J. Cardiol. 17:(3):1987;465-474. [Abstract in English].
13. Wigle E.D., Sasson Z., Henderson M.A., Ruddy T.D., Fulop J., Rakowski H., et al. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog. Cardiovasc. Dis. 28:1985;1-83.
14. D. Losi M.A., Betocchi S., Grimaldi M. Heterogenity of left ventricular filling dynamics in hypertrophic cardiomyopathy. Am. J. Cardiol. 73:1994;987-990.
15. Akasaka K., Kawashima E., Shiokoshi T., Ishii Y., Hasebe N., Kikuchi K. Left atrial function and left atrial appendage flow velocity in hypertrophic cardiomyopathy: comparison of patients with and without paroxysmal atrial fibrillation. J. Cardiol. 32:(1):1998;31-38. [Abstract in English].
16. Spirito P., Lakatos E., Maron B.J. Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. Am. J. Cardiol. 69:(14):1992;1217-1222.
17. Brembilla-Perrot B., Terrier de La Chaise A., Beurrier D. Paroxysmal atrial fibrillation: main cause of syncope in hypertrophic cardiomyopathy. Arch. Mal. Coeur Vaiss. 86:(11):1993;1573-1578.
18. Hazen M.S., Marwick T.H., Underwood D.A. Diagnostic accuracy of the resting electrocardiogram in detection and estimation of left atrial enlargement: an echocardiographic correlation in 551 patients. Am. Heart J. 122:1991;823.
19. Dilaveris P.E., Gialafos E.J., Sideris S.K., Theopistou A.M., Andrikoupoulos G.K., Kyriadis M., et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am. Heart J. 135:1998;733-738.
20. Cecchi F., Montereggi A., Olivotto I., Marconi P., Dolara A., Maron B.J. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P-wave duration. Heart. 7881:1997;44-49.